Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received January 29, 2021
- Revision received March 15, 2021
- Accepted March 23, 2021
- Published first March 29, 2021.
Copyright & Usage
Copyright ©2021, American Association for Cancer Research.
Author Information
- Julian A Abrams1,*,
- Armando Del Portillo2,
- Caitlin Hills2,
- Griselda Compres3,
- Richard A. Friedman4,
- Bin Cheng5,
- John Poneros3,
- Charles J. Lightdale6,
- Rachel de la Rue7,
- Massimiliano di Pietro7,
- Rebecca C. Fitzgerald8,
- Antonia Sepulveda9, and
- Timothy C. Wang10
- 1Department of Medicine, Columbia University Irving Medical Center
- 2Pathology and Cell Biology, Columbia University Irving Medical Center
- 3Columbia University Medical Center
- 4Biomedical Informatics Shared Resource, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center
- 5Biostatistics, Mailman School of Public Health
- 6Division of Digestive and Liver Diseases, Columbia University Medical Center
- 7University of Cambridge
- 8Hutchison/MRC Research Centre (Box 197), University of Cambridge
- 9George Washington University
- 10Medicine, Columbia University Medical Center
- ↵* Corresponding Author:
Julian A Abrams, Department of Medicine, Columbia University Irving Medical Center, 630 W 168th St, P&S 3-401, New York, NY, 10032, United States. E-mail: ja660{at}cumc.columbia.edu
This OnlineFirst version was published on March 29, 2021
doi: 10.1158/1940-6207.CAPR-21-0050
Randomized Controlled Trial of the Gastrin/CCK2 Receptor Antagonist Netazepide in Patients with Barrett's Esophagus
Jump to section
Advertisement